J. Gea-Banacloche

发表

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

Mitchell M. Levy, Margaret M. Parker, Janice L. Zimmerman, 2004, Critical care medicine.

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

Margaret M Parker, Herwig Gerlach, Graham Ramsay, 2004, Critical care medicine.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

G. Illei, J. Cohen, J. Gea-Banacloche, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Invasive Candidiasis in Management of Infections in Cancer Patients

M. Bassetti, C. Viscoli, J. Gea-Banacloche, 2011 .

Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis in Rheumatologic Disease

J. Gea-Banacloche, Ayan Sen, Y. Kusne, 2021, Case reports in critical care.

Fungal Infections in Neutropenic Patients

J. Gea-Banacloche, T. Walsh, A. Groll, 2011 .

Targeted pretransplant host lymphocyte depletion prior to T‐cell depleted reduced‐intensity allogeneic stem cell transplantation

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, British journal of haematology.

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.

W. Wilson, S. Steinberg, J. Hou, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

Thomas E. Hughes, S. Holland, C. Zerbe, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health (NIH) Chronic GVHD Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

J. Shelhamer, J. Gea-Banacloche, K. Baird, 2013 .

Sepsis associated with immunosuppressive medications: An evidence-based review

S. Opal, J. Carcillo, K. Sepkowitz, 2004, Critical care medicine.

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

Sadik H. Kassim, W. Telford, S. Rosenberg, 2013 .

Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

S. Steinberg, B. Levine, C. June, 2011, Clinical Cancer Research.

Discrepant results from sampling different lumens of multilumen catheters: the case for sampling all lumens

J. Gea-Banacloche, P. Murray, J. Cuellar-Rodríguez, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.

S. Steinberg, B. Levine, C. June, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant.

W. Wilson, B. Levine, C. June, 2002, Cytotherapy.

Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin.

P. Murray, J. Gea-Banacloche, O. Green, 2008, Diagnostic microbiology and infectious disease.

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection

S. Holland, K. Oetjen, Catherine Lai, 2017, Leukemia research reports.

Granulocyte transfusions: A concise review for practitioners.

J. Gea-Banacloche, 2017, Cytotherapy.

Immune reconstitution in HIV infection.

J. Gea-Banacloche, H. Clifford Lane, 1999, AIDS.

Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.

S. Holland, A. Hsu, C. Zerbe, 2011, Blood.

Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.

S. Steinberg, M. Bishop, D. Danforth, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis.

S. Steinberg, Stephanie J. Lee, J. Gea-Banacloche, 2022, Transplantation and cellular therapy.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Clinical pharmacology of antifungal compounds.

A. Glasmacher, J. Gea-Banacloche, T. Walsh, 2003, Infectious disease clinics of North America.

Mild to moderate COVID-19 illness in adult outpatients

J. Gea-Banacloche, M. Burns, J. Blair, 2021, Medicine.

Rituximab-associated infections.

J. Gea-Banacloche, 2010, Seminars in hematology.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

S. Rosenberg, J. Yang, S. Topalian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.

J. Gea-Banacloche, T. Hilal, J. Leis, 2018, Blood reviews.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

W. Wilson, S. Steinberg, M. Bishop, 2006 .

Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.

H. Einsele, H. Greinix, J. Gea-Banacloche, 2011, Vaccine.

Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study.

S. Vesely, P. Choyke, J. Havlicek, 2018, The Lancet. Haematology.

Granulocyte transfusions in the management of invasive fungal infections

Sameer S. Kadri, D. Stroncek, J. Gea-Banacloche, 2017, British journal of haematology.

Antiviral cell therapy: is this the future?

J. Gea-Banacloche, 2013, Blood.

Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib.

A. Wiestner, J. Gea-Banacloche, I. Ahn, 2016, Blood.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.

M. Turner, J. Gea-Banacloche, K. Baird, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biomarkers in fever and neutropenia: a solution in search of a problem?

J. Gea-Banacloche, 2011, Critical care medicine.

Antibacterial prophylaxis reduced the incidence of fever in patients receiving chemotherapy for solid tumors or lymphoma.

J. Gea-Banacloche, 2006, ACP journal club.

Pulmonary infectious complications after hematopoietic stem cell transplantation: a practical guide to clinicians

J. Gea-Banacloche, 2018, Current opinion in organ transplantation.

Disseminated Microsporidiosis in an Immunosuppressed Patient

J. Gea-Banacloche, J. Bennett, Y. Qvarnstrom, 2012, Emerging infectious diseases.

Hallucinations during voriconazole therapy.

J. Gea-Banacloche, R. Childs, J. Bennett, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine

R. Danner, J. Gea-Banacloche, B. Moriyama, 2009, Antimicrobial Agents and Chemotherapy.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risks and Epidemiology of Infections After Hematopoietic Stem Cell Transplantation

J. Gea-Banacloche, 2016, Transplant Infections.

Role of granulocyte transfusions in invasive fusariosis: systematic review and single‐center experience

Sameer S. Kadri, J. Gea-Banacloche, S. Leitman, 2015, Transfusion.

Granulocyte transfusions: where is the controversy?

J. Gea-Banacloche, 2011, Cytotherapy.

Coccidioidomycosis in Allogeneic Stem Cell Transplant Recipients: Case Series and Review of the Literature

J. Gea-Banacloche, J. Blair, Christopher F. Saling, 2021, Journal of fungi.

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

L. Staudt, W. Wilson, S. Steinberg, 2017, Cancer cell.

Death by Edible Mushroom: First Report of Volvariella volvacea as an Etiologic Agent of Invasive Disease in a Patient following Double Umbilical Cord Blood Transplantation

G. Fahle, M. Bishop, J. Gea-Banacloche, 2010, Journal of Clinical Microbiology.

Monoclonal antibody therapeutics and risk for infection.

J. Gea-Banacloche, G. Weinberg, 2007, The Pediatric infectious disease journal.

The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.

J. Gea-Banacloche, D. Fedorko, M. Lionakis, 2014, The Journal of infection.

Pharmacokinetics of Anidulafungin in Pleural Fluid during the Treatment of a Patient with Candida Empyema

R. Danner, J. Gea-Banacloche, B. Moriyama, 2011, Antimicrobial Agents and Chemotherapy.

Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantation.

J. Gea-Banacloche, J. Wade, 2009, Cancer treatment and research.

Regionally limited or rare infections: prevention after hematopoietic cell transplantation

H. Masur, J. Gea-Banacloche, T. Chiller, 2010, Bone Marrow Transplantation.

The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients

S. Fischer, G. Storch, J. Gea-Banacloche, 2007, Bone Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

West Nile Virus: Pathogenesis and Therapeutic Options

A. Bagić, J. Butman, J. Gea-Banacloche, 2004, Annals of Internal Medicine.

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

S. Rosenberg, J. Gea-Banacloche, S. Feldman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

Sadik H. Kassim, W. Telford, S. Rosenberg, 2013, Blood.

Maintenance of Large Numbers of Virus-Specific CD8+ T Cells in HIV-Infected Progressors and Long-Term Nonprogressors

C. Hallahan, S. Migueles, M. Connors, 2000, The Journal of Immunology.

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Smita Y. Patel, Steven M Holland, M. Raffeld, 2011, Blood.

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

H. Clifford Lane, Mark Connors, Julia A. Metcalf, 1997, Nature Medicine.

National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

J. Shelhamer, S. Steinberg, J. Gea-Banacloche, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients.

S. Steinberg, M. Bishop, S. Kummar, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplant For GATA2 Deficiency

S. Holland, C. Zerbe, T. Fry, 2013 .

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

H. Kong, S. Holland, C. Bollard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.

W. Quint, Sarah Wagner, M. Schiffman, 2020, JAMA oncology.

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation

G. Fahle, A. Nath, A. Freeman, 2013, Neurology.

Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid.

A. Vortmeyer, J. Gea-Banacloche, S. Jacobson, 2007, The Journal of infectious diseases.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.

S. Steinberg, S. Pittaluga, M. Bishop, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

C. Hallahan, M. Baseler, J. Falloon, 1998, The Journal of infectious diseases.

Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.

C. Hallahan, M. Baseler, M. Polis, 2000, AIDS research and human retroviruses.

Progressors and Long-Term Nonprogressors T Cells in HIV-Infected + Virus-Specific CD 8 Maintenance of Large Numbers of

C. Hallahan, S. Migueles, M. Connors, 2000 .

Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.

J. Gea-Banacloche, 2013, Hematology. American Society of Hematology. Education Program.

Interleukin 2 leads to dose-dependent expression of the alpha chain of the IL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation.

C. Hallahan, H. Lane, J. Gea-Banacloche, 2000, Clinical immunology.

Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation

J. Gea-Banacloche, A. Callejas-Díaz, A. Callejas-Diaz, 2014, Current Hematologic Malignancy Reports.

Infectious complications of chimeric antigen receptor (CAR) T-cell therapies.

J. Gea-Banacloche, 2023, Seminars in hematology.

Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease

J. Shelhamer, Stephanie J. Lee, J. Gea-Banacloche, 2013 .

Abstracts from Scientific Programme

P. Lipsky, J. Gea-Banacloche, P. Muraro, 2010, Bone Marrow Transplantation.

Erratum: Regionally limited or rare infections: Prevention after hematopoietic cell transplantation (Bone Marrow Transplantation (2009) 44 (489-494) DOI: 10.1038/bmt.2009.260)

H. Masur, J. Gea-Banacloche, T. Chiller, 2010 .

Granulocytic invasion of the central nervous system after hematopoietic stem cell transplantation for systemic lupus erythematosus.

P. Lipsky, G. Illei, J. Butman, 2006, Haematologica.

Resistance to Replication of Human Immunodeficiency Virus Challenge in SCID-Hu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+T Cells and Associated with a Proliferative Response to p24 Antigen

C. Hallahan, R. Davey, M. Connors, 2000, Journal of Virology.

Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma.

L. Staudt, W. Wilson, E. Jaffe, 2004 .

Infectious Complications Associated with CAR T-Cell Therapy

S. Steinberg, T. Palmore, R. Kaplan, 2019, Blood.

Discrepant results from sampling different lumens of multilumen catheters: the case for sampling all lumens

J. Gea-Banacloche, P. Murray, J. Cuellar-Rodríguez, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection

R. Bonomo, Jamie K. Lemon, J. Gea-Banacloche, 2019, mBio.

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

S. Pittaluga, M. Bagheri, D. Stroncek, 2016 .

Infections following rejection therapies in kidney and liver transplant recipients

J. Gea-Banacloche, R. Heilman, D. Chascsa, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock

M. Levy, J. Marshall, J. Vincent, 2022 .

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Smita Y. Patel, M. Raffeld, S. Pittaluga, 2011, Blood.

Role of granulocyte transfusions in invasive fusariosis: systematic review and single‐center experience

J. Gea-Banacloche, S. Leitman, K. Remy, 2015, Transfusion.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

L. Staudt, S. Steinberg, E. Jaffe, 2017, Cancer cell.

Abbreviated Treatment with Short-Course Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Is Highly Effective in AIDS-Related Lymphoma (ARL).

S. Steinberg, E. Jaffe, S. Pittaluga, 2004 .